DNA released by leukemic cells contributes to the disruption of the bone marrow microenvironment.
- Published in:
- Oncogene, 2013, v. 32, n. 44, p. 5201, doi. 10.1038/onc.2012.553
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 44
Results: 7
1
2
Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.
- Published in:
- Oncogene, 2013, v. 32, n. 44, p. 5241, doi. 10.1038/onc.2012.549
- By:
- Publication type:
- Article
3
SARA and RNF11 interact with each other and ESCRT-0 core proteins and regulate degradative EGFR trafficking.
- Published in:
- Oncogene, 2013, v. 32, n. 44, p. 5220, doi. 10.1038/onc.2012.554
- By:
- Publication type:
- Article
4
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
- Published in:
- Oncogene, 2013, v. 32, n. 44, p. 5210, doi. 10.1038/onc.2012.550
- By:
- Publication type:
- Article
5
DNA: leukemia's secret weapon of bone mass destruction.
- Published in:
- Oncogene, 2013, v. 32, n. 44, p. 5199, doi. 10.1038/onc.2012.639
- By:
- Publication type:
- Article
6
Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
- Published in:
- Oncogene, 2013, v. 32, n. 44, p. 5233, doi. 10.1038/onc.2012.558
- By:
- Publication type:
- Article
7
Redox regulation in stem-like cancer cells by CD44 variant isoforms.
- Published in:
- Oncogene, 2013, v. 32, n. 44, p. 5191, doi. 10.1038/onc.2012.638
- By:
- Publication type:
- Article